Coiled-coil domain-containing 92B (CCDC92B)

CCDC92B (Coiled-coil domain-containing 92B) is a human protein that is encoded by the CCDC92B gene (HGNC: 52279, NCBI Gene: 101928991, Ensembl: ENSG00000277200)[7][10]. It is a paralog of CCDC92, but there is no evidence that CCDC92B acts as a receptor, enzyme, transporter, or recognized therapeutic target[7][10]. There is no established biological function, disease association, or role in drug response for CCDC92B in current gene annotation databases[7][10][9]. There is also no information about interacting drugs, mechanism of action, clinical biomarkers, or salient safety concerns. No Gene Ontology, Human Protein Atlas, UniProt, or Open Targets records support a therapeutic target function or defined molecular/physiological role for this protein or its gene in humans[7][10][9][8]. While the highly related gene CCDC92 (Coiled-coil domain-containing 92) has some predicted biological roles such as participation in innate immune response or viral defense (including inhibition of ebolavirus replication)[2][1], CCDC92B itself should not be conflated with these activities. The available evidence suggests that CCDC92B is not currently characterized as a therapeutic or biomarker-relevant target and lacks detailed biological or disease associations. Because of the near-absence of curated data, CCDC92B is not considered a validated or characterized therapeutic target and may be queried in error when seeking a well-known protein, such as CCDC92[7][10][9].

Other names

Coiled-coil domain containing 92BCCDC92B